AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zesita M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Lakshya Life Sciences

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Zesita M 50mg/500mg Tablet

Diabetics with type 2 mellitus may find relief from elevated blood glucose with the dual-action formulation of Metformin/Glibenclamide 50mg/500mg tablets. This medication helps mitigate the risk of severe diabetic complications, such as renal impairment and vision loss, and potentially lowers the likelihood of cardiovascular events. This treatment may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when coupled with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Ingesting the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time each day, maximizes therapeutic efficacy; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial. Lifestyle modifications are integral to effective diabetes management. Commonly reported side effects include nausea, diarrhea, vomiting, stomach upset, headache, and pharyngitis. Hypoglycemia, especially when combined with insulin or sulfonylureas, is a potential adverse effect requiring awareness and prompt management. Prior to commencing treatment, patients should inform their physician of any pre-existing kidney, liver, or cardiac conditions, pancreatic issues, or excessive alcohol consumption. Pregnant or lactating women require medical consultation before initiating therapy. Potential drug interactions necessitate a comprehensive review of all current medications with your physician to ensure safety. Alcohol intake should be limited due to its potential for hypoglycemia. Regular monitoring of renal function and blood glucose levels is a standard component of treatment.

Uses of Zesita M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Zesita M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or breaking it. The Zesita M 50mg/500mg Tablet should be administered with a meal.

Common Side effects of Zesita M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Zesita M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Zesita M 50mg/500mg Tablet should be administered with food.

How Zesita M 50mg/500mg Tablet works:

Zesita M 50mg/500mg tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, works by decreasing liver glucose production, slowing intestinal glucose absorption, and boosting insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Zesita M 50mg/500mg Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zesita M 50mg/500mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Zesita M 50mg/500mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Caution is advised when prescribing Zesita M 50mg/500mg Tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. The use of Zesita M 50mg/500mg Tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Zesita M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Zesita M 50mg/500mg Tablet :

Should you forget a Zesita M 50mg/500mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual regimen. Never take a double dose.

Facts to Know About Zesita M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes medication

FAQs on Zesita M 50mg/500mg Tablet

Zesita M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Zesita M 50mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Zesita M 50mg/500mg Tablets may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Zesita M 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Zesita M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Zesita M 50mg/500mg tablets. This rare complication is more likely in individuals with kidney disease, the elderly, or those who consume significant amounts of alcohol, hence its avoidance in these groups. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience any of these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Zesita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Zesita M 50mg/500mg Tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may result in vitamin B12 deficiency.
Zesita M 50mg/500mg Tablets are contraindicated in patients with known allergies to any of its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Zesita M 50mg/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Zesita M 50mg/500mg Tablet (containing metformin) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA – Metformin-Associated Lactic Acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Zesita M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may cause anemia, neurological issues like numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the label's instructions. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Zesita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Zesita M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Zesita M 50mg/500mg Tablets are contraindicated in patients with known allergies to any of its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Zesita M 50mg/500mg Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Zesita M 50mg/500mg Tablet. This occurs due to excess lactic acid in the bloodstream and is rare, but avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Zesita M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, along with potential cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Zesita M 50mg/500mg Table...
128
MRP 149
14% off